My Quote Request
No products added yet
6505-01-501-5378
20 Products
NDC00517-9120-25
AMINOCAPROIC ACID INJECTION,USP
NSN, MFG P/N
6505015015378
NSN
6505-01-501-5378
NDC00517-9120-25
AMINOCAPROIC ACID INJECTION,USP
NSN, MFG P/N
6505015015378
NSN
6505-01-501-5378
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201216
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID INJECTION USP 250MG/ML 20ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FLIPTOP VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
02-1502
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505015015408
NSN
6505-01-501-5408
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 402000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 50ML SYRINGE PG 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
SPECIAL FEATURES: LEUR LOCK SYRINGE,NEEDLELESS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ANSYR
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505015015408
NSN
6505-01-501-5408
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 402000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 50ML SYRINGE PG 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
SPECIAL FEATURES: LEUR LOCK SYRINGE,NEEDLELESS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-7517-16
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505015015408
NSN
6505-01-501-5408
NDC00074-7517-16
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505015015408
NSN
6505-01-501-5408
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 402000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 50ML SYRINGE PG 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE-NEEDLE UNIT
SPECIAL FEATURES: LEUR LOCK SYRINGE,NEEDLELESS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
02-1561
PENTOBARBITAL SODIUM INJECTION,USP
NSN, MFG P/N
6505015015438
NSN
6505-01-501-5438
02-1561
PENTOBARBITAL SODIUM INJECTION,USP
NSN, MFG P/N
6505015015438
NSN
6505-01-501-5438
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PENTOBARBITAL SODIUM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282404
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTOBARBITAL SODIUM INJECTION USP 50MG/ML 20ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: STORE AT ROOM TEMP.; MAY BE HABIT FORMING
Related Searches:
NDC67386-0501-52
PENTOBARBITAL SODIUM INJECTION,USP
NSN, MFG P/N
6505015015438
NSN
6505-01-501-5438
NDC67386-0501-52
PENTOBARBITAL SODIUM INJECTION,USP
NSN, MFG P/N
6505015015438
NSN
6505-01-501-5438
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PENTOBARBITAL SODIUM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282404
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTOBARBITAL SODIUM INJECTION USP 50MG/ML 20ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: STORE AT ROOM TEMP.; MAY BE HABIT FORMING
Related Searches:
02-1481
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
02-1481
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 5ML VIAL 25S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CAN BE ADMINISTERED SUBCUTANEOUS; LIFESHIELD FLIPTOP GLASS VIALS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00074-2102-05
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
NDC00074-2102-05
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
MFG
ABBOTT LABORATORIES INC. DIV PHARMACEUTICAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 5ML VIAL 25S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CAN BE ADMINISTERED SUBCUTANEOUS; LIFESHIELD FLIPTOP GLASS VIALS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00409-2102-05
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
NDC00409-2102-05
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015017516
NSN
6505-01-501-7516
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 5ML VIAL 25S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CAN BE ADMINISTERED SUBCUTANEOUS; LIFESHIELD FLIPTOP GLASS VIALS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
02-1489
LAMIVADINE-ZIDOVADI
NSN, MFG P/N
6505015019585
NSN
6505-01-501-9585
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVADINE ZIDOVADINE TABLETS USP TO TREAT HIV 6S
III SUPPLEMENTARY FEATURES: FOR USE IN THE HIV KIT
SPECIAL FEATURES: COMBINATION OF 2 ANTIVIRAL MEDICATIONS: 150MG LAMIVUDINE AND 300MG ZIDOVUDINE; TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TO BE PLACED IN THE HIV KIT; KEEP MEDICATION TIGHTLY CLOSED AT ROOM TEMPERATURE; PKG. OF 6 FILM-COATED TABLETS
Related Searches:
6505NCM010194
LAMIVADINE-ZIDOVADI
NSN, MFG P/N
6505015019585
NSN
6505-01-501-9585
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVADINE ZIDOVADINE TABLETS USP TO TREAT HIV 6S
III SUPPLEMENTARY FEATURES: FOR USE IN THE HIV KIT
SPECIAL FEATURES: COMBINATION OF 2 ANTIVIRAL MEDICATIONS: 150MG LAMIVUDINE AND 300MG ZIDOVUDINE; TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TO BE PLACED IN THE HIV KIT; KEEP MEDICATION TIGHTLY CLOSED AT ROOM TEMPERATURE; PKG. OF 6 FILM-COATED TABLETS
Related Searches:
COMBIVIR
LAMIVADINE-ZIDOVADI
NSN, MFG P/N
6505015019585
NSN
6505-01-501-9585
MFG
PD-RX PHARMACEUTICALS INC DBA TRIMARC LABORATORIES
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVADINE ZIDOVADINE TABLETS USP TO TREAT HIV 6S
III SUPPLEMENTARY FEATURES: FOR USE IN THE HIV KIT
SPECIAL FEATURES: COMBINATION OF 2 ANTIVIRAL MEDICATIONS: 150MG LAMIVUDINE AND 300MG ZIDOVUDINE; TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TO BE PLACED IN THE HIV KIT; KEEP MEDICATION TIGHTLY CLOSED AT ROOM TEMPERATURE; PKG. OF 6 FILM-COATED TABLETS
Related Searches:
NDC54569-4524-01
LAMIVADINE-ZIDOVADI
NSN, MFG P/N
6505015019585
NSN
6505-01-501-9585
MFG
ALLSCRIPTS HEALTHCARE SOLUTIONS INC
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVADINE ZIDOVADINE TABLETS USP TO TREAT HIV 6S
III SUPPLEMENTARY FEATURES: FOR USE IN THE HIV KIT
SPECIAL FEATURES: COMBINATION OF 2 ANTIVIRAL MEDICATIONS: 150MG LAMIVUDINE AND 300MG ZIDOVUDINE; TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TO BE PLACED IN THE HIV KIT; KEEP MEDICATION TIGHTLY CLOSED AT ROOM TEMPERATURE; PKG. OF 6 FILM-COATED TABLETS
Related Searches:
NDC55289-0389-06
LAMIVADINE-ZIDOVADI
NSN, MFG P/N
6505015019585
NSN
6505-01-501-9585
MFG
PD-RX PHARMACEUTICALS INC DBA TRIMARC LABORATORIES
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVADINE ZIDOVADINE TABLETS USP TO TREAT HIV 6S
III SUPPLEMENTARY FEATURES: FOR USE IN THE HIV KIT
SPECIAL FEATURES: COMBINATION OF 2 ANTIVIRAL MEDICATIONS: 150MG LAMIVUDINE AND 300MG ZIDOVUDINE; TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TO BE PLACED IN THE HIV KIT; KEEP MEDICATION TIGHTLY CLOSED AT ROOM TEMPERATURE; PKG. OF 6 FILM-COATED TABLETS
Related Searches:
02-1569
ISOSORBIDE DINITRATE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015022984
NSN
6505-01-502-2984
02-1569
ISOSORBIDE DINITRATE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015022984
NSN
6505-01-502-2984
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 241200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE EXTENDED RELEASE TABLETS USP 40MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PRESERVE IN WELL CLOSED CONTAINERS
Related Searches:
NDC00258-3613-01
ISOSORBIDE DINITRATE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015022984
NSN
6505-01-502-2984
NDC00258-3613-01
ISOSORBIDE DINITRATE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015022984
NSN
6505-01-502-2984
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 241200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOSORBIDE DINITRATE EXTENDED RELEASE TABLETS USP 40MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PRESERVE IN WELL CLOSED CONTAINERS
Related Searches:
02-1532
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
02-1532
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN TABLETS DELAYED RELEASE USP 325MG BT 100S
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: REGULAR STRENGTH; FOR TEMPORARY RELIEF OF MINOR ACHES, PAINS, AND INFLAMMATION OF ARTHRITIS AND RHEUMATISM, ANTIPLATELET; STORE AT CONTROLLED ROOM TEMPERATURE (59 TO 88 DERGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
6505NCM020936
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
6505NCM020936
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN TABLETS DELAYED RELEASE USP 325MG BT 100S
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: REGULAR STRENGTH; FOR TEMPORARY RELIEF OF MINOR ACHES, PAINS, AND INFLAMMATION OF ARTHRITIS AND RHEUMATISM, ANTIPLATELET; STORE AT CONTROLLED ROOM TEMPERATURE (59 TO 88 DERGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00603-0166-21
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
NDC00603-0166-21
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505015023905
NSN
6505-01-502-3905
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN TABLETS DELAYED RELEASE USP 325MG BT 100S
LONG ACTION METHOD: DELAYED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: REGULAR STRENGTH; FOR TEMPORARY RELIEF OF MINOR ACHES, PAINS, AND INFLAMMATION OF ARTHRITIS AND RHEUMATISM, ANTIPLATELET; STORE AT CONTROLLED ROOM TEMPERATURE (59 TO 88 DERGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
02-1570
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505015025524
NSN
6505-01-502-5524
02-1570
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505015025524
NSN
6505-01-502-5524
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 85.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 366800
FLAVOR: ANY ACCEPTABLE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES OR 340.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
SPECIAL FEATURES: STRAWS ARE AVAILABLE FREE UPON REQUEST (P/N:841)
TOTAL PRIMARY CONTAINER QUANTITY: 24
